Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kersting

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
EJNMMI Physics|April 16, 2025
External phantom-based validation of a deep-learning network trained for upscaling of digital low count PET dataAnja Braune, René Hosch, David Kersting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Reply: Recent Evidence on Cardiac <sup>99m</sup>Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR AmyloidosisChristoph Rischpler, David Kersting, Lukas Kessler, et al.
Endocrine-Related Cancer|January 16, 2026
Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTCYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2021
Repeatability of <sup>68</sup>Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor VolumeRobert Seifert, Patrick Sandach, David Kersting, et al.
Theranostics|August 10, 2021
Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapyRobert Seifert, Katharina Kessel, Katrin Schlack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2021
Just another "Clever Hans"? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancerManuel Weber, David Kersting, Lale Umutlu, et al.
Seminars in Nuclear Medicine|March 16, 2024
Imaging of Cardiac Fibrosis: How Far Have We Moved From Extracellular to Cellular?Tugce Telli, Atefeh Hosseini, Stephan Settelmeier, et al.
Medical Physics|November 26, 2024
Detection and quantification of small and low-uptake lesions for differentiated thyroid carcinoma using non-time-of-flight iodine-124 PET/MRIMaike E Lindemann, Walter Jentzen, David Kersting, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 26, 2021
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom studyPedro Fragoso Costa, Walter Jentzen, Finja SÜßELBECK, et al.
Molecular Genetics & Genomic Medicine|December 21, 2020
Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature reviewMaria Papathanasiou, Alexander Carpinteiro, David Kersting, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
EJNMMI Physics|April 16, 2025
External phantom-based validation of a deep-learning network trained for upscaling of digital low count PET dataAnja Braune, René Hosch, David Kersting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Reply: Recent Evidence on Cardiac <sup>99m</sup>Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR AmyloidosisChristoph Rischpler, David Kersting, Lukas Kessler, et al.
Endocrine-Related Cancer|January 16, 2026
Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTCYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2021
Repeatability of <sup>68</sup>Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor VolumeRobert Seifert, Patrick Sandach, David Kersting, et al.
Theranostics|August 10, 2021
Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapyRobert Seifert, Katharina Kessel, Katrin Schlack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2021
Just another "Clever Hans"? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancerManuel Weber, David Kersting, Lale Umutlu, et al.
Seminars in Nuclear Medicine|March 16, 2024
Imaging of Cardiac Fibrosis: How Far Have We Moved From Extracellular to Cellular?Tugce Telli, Atefeh Hosseini, Stephan Settelmeier, et al.
Medical Physics|November 26, 2024
Detection and quantification of small and low-uptake lesions for differentiated thyroid carcinoma using non-time-of-flight iodine-124 PET/MRIMaike E Lindemann, Walter Jentzen, David Kersting, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 26, 2021
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom studyPedro Fragoso Costa, Walter Jentzen, Finja SÜßELBECK, et al.
Molecular Genetics & Genomic Medicine|December 21, 2020
Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature reviewMaria Papathanasiou, Alexander Carpinteiro, David Kersting, et al.
Pageof 9